Pharma Data Mining Restriction Options Available
The PDRP "enables physicians to ‘opt out’ of such disclosure quickly and easily, while still allowing their data to be available for academic and governmental research," the AMA statement said.
“We believe the PDRP balances individual physician concerns regarding prescription data with First Amendment freedoms and the fundamental public interest in robust medical research."
Mello and Messing said the Supreme Court decision "may offer an unexpected dividend to opponents of data mining: The surrounding publicity might alert physicians to their right to opt out of sharing their prescribing information through the PDRP."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers
- Acute Kidney Injury Gets New Focus
- mHealth Tackles Readmissions
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- States Without Medicaid Expansion Search for Alternatives
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Interventional Radiology No Longer a Sub-Specialty